세계의 임상 진단 시장

Highlights:

The global market for clinical diagnostics reached $67.8 billion in 2022. The market is estimated to grow from $73.1 billion in 2023 to reach $103.4 billion by 2028, at a compound annual growth rate (CAGR) of 7.2% from 2023 through 2028.

The lipid panel segment of the global clinical diagnostics market is estimated to grow from $28.1 billion in 2023 to reach $40.3 billion by 2028, at a CAGR of 7.5% from 2023 through 2028.

The infectious disease testing segment of the global clinical diagnostics market is estimated to grow from $19.5 billion in 2023 to reach $28.4 billion by 2028, at a CAGR of 7.8% from 2023 through 2028.

Report Scope:

This report aims to provide a comprehensive study of the global market for clinical diagnostics, both quantitative and qualitative data, to help executives develop corporate growth strategies, assess the market landscape, analyze their positions in the current marketplace, and make informed business decisions regarding clinical diagnostics.

An in-depth market analysis includes historical data and market projections on sales by type of test, product type, application, end user and region. It describes the different types of clinical diagnostic tests and their current and historical market revenues. This report also categorizes the global clinical diagnostic market based on four geographic regions: North America, Europe, Asia-Pacific and the Rest of the World (RoW).

For a more in-depth understanding of the market, the report provides profiles of leading companies and their respective market shares.

Report Includes:

• 22 data tables
• An up-to-date overview and analysis of the global clinical diagnostics market
• Analyses of the global market trends, with historic market revenue data (sales figures) from 2020-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
• Discussion of the major growth drivers, opportunities and challenges, technology updates, and the impact of macroeconomic variables influencing the market for clinical diagnostics as a basis for projecting demand in the next few years (2023-2028)
• Estimation of the actual market size and revenue forecast for global clinical diagnostics market, and corresponding market share analysis based on the type of test, product and service, application, end user, and region
• In-depth information (facts and figures) concerning the major market dynamics, screening tools and techniques, regulatory developments, new and emerging technologies, and current competitive landscape of the clinical diagnostic market
• Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
• Descriptive company profiles of the leading global players, including Abbott Laboratories, Bio-Rad Laboratories Inc., Siemens Healthineers, Roche Diagnostics, Qiagen and Thermo Fisher Scientific Inc.

Table of Contents

Chapter 1 Introduction

• 1.1 Improved Patient Outcomes
• 1.2 Improved Public Health
• 1.3 Reduced Healthcare Costs
• 1.4 Study Goals and Objectives
• 1.5 Reasons for Doing the Study
• 1.6 Scope of Report
• 1.7 Methodology and Information Sources
• 1.8 Geographic Breakdown
• 1.9 Analyst's Credentials
• 1.10 BCC Custom Research
• 1.11 Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

• 3.1 Overview
• 3.2 Quality Control
• 3.3 Quality Assurance
• 3.4 Turnaround Time
• 3.5 Clinical Correlation
• 3.6 Accuracy and Reliability
• 3.7 Patient Safety
  • 3.7.1 Cancer Screening
  • 3.7.2 Newborn Screening
  • 3.7.3 Infectious Disease Screening
  • 3.7.4 Cardiovascular Disease Screening
• 3.8 Types of Screening
• 3.9 Screening Tests
• 3.10 Screening Guidelines
• 3.11 Benefits of Screening
• 3.12 Limitations of Screening
• 3.13 Genetic Testing
• 3.14 Pharmacogenomics
• 3.15 Biomarker Testing
• 3.16 Proteomics
• 3.17 Metabolomics

Chapter 4 Clinical Diagnostics Market Breakdown by Type of Test

• 4.1 Introduction
  • 4.1.1 Lipid Panels
  • 4.1.2 Infectious Disease Testing
  • 4.1.3 Complete Blood Count
  • 4.1.4 Metabolic Panel Testing
  • 4.1.5 Abnormal Metabolic Panel Results
  • 4.1.6 Other Tests

Chapter 5 Clinical Diagnostics Market Breakdown by Product Type

• 5.1 Introduction
• 5.2 Assays and Kits
  • 5.2.1 Types of Assays and Kits in Clinical Diagnostics
• 5.3 Instruments
  • 5.3.1 Types of Instruments
• 5.4 Reagents
  • 5.4.1 Types of Reagents
• 5.5 Software and Services
  • 5.5.1 Data Management

Chapter 6 Clinical Diagnostics Market Breakdown by Application

• 6.1 Introduction
• 6.2 Infectious Diseases
• 6.3 Cancer
  • 6.3.1 Types of Cancer
  • 6.3.2 Causes of Cancer
  • 6.3.3 Symptoms of Cancer
  • 6.3.4 Diagnosis of Cancer
  • 6.3.5 Treatment of Cancer
• 6.4 Cardiovascular Disease

Chapter 7 Clinical Diagnostics Market Breakdown by End User

• 7.1 Introduction
• 7.2 Diagnostic Laboratories
• 7.3 Hospitals and Clinics
• 7.4 Other End Users

Chapter 8 Clinical Diagnostics Market Breakdown by Region

• 8.1 Introduction
• 8.2 Global Market Size and Forecast
• 8.3 North America
  • 8.3.1 United States
  • 8.3.2 Canada
• 8.4 Europe
  • 8.4.1 Germany
  • 8.4.2 United Kingdom
• 8.5 Asia-Pacific
• 8.6 Rest of the World

Chapter 9 Market Dynamics

• 9.1 Market Drivers
  • 9.1.1 Advances in Technology
  • 9.1.2 Increasing Prevalence of Chronic and Infectious Diseases
  • 9.1.3 Autoimmune Disorders
  • 9.1.4 Aging Population
  • 9.1.5 Rising Healthcare Expenditures
  • 9.1.6 Point-of-Care Testing
  • 9.1.7 Personalized Medicine
• 9.2 Market Challenges
  • 9.2.1 Stringent Regulatory Scenario
  • 9.2.2 Reimbursement Challenges
  • 9.2.3 Increasing Market Competition

Chapter 10 Emerging Technologies

• 10.1 Molecular Diagnostics
• 10.2 Next-Generation Sequencing (NGS)
• 10.3 Point-of-Care Testing
• 10.4 Artificial Intelligence (AI)
• 10.5 Other Emerging Techniques

Chapter 11 Competitive Landscape

• 11.1 Overview

Chapter 12 Company Profiles

• ABBOTT LABORATORIES
• BECTON, DICKINSON AND CO.
• BIOMERIEUX S.A.
• BIO-RAD LABORATORIES INC.
• DANAHER CORP.
• F. HOFFMANN-LA ROCHE LTD.
• QIAGEN N.V.
• SIEMENS HEALTHINEERS AG
• THERMO FISHER SCIENTIFIC INC.